[1]
|
陈双双, 马锐. 多原发癌的研究进展[J]. 癌症进展, 2019, 17(8): 883-886.
|
[2]
|
Rostad, H., Strand, T.E., Naalsund, A., et al. (2008) Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study. The Annals of Thoracic Surgery, 85, 204-209. https://doi.org/10.1016/j.athoracsur.2007.07.091
|
[3]
|
Yu, Y.C., Hsu, P.K., Yeh, Y.C., et al. (2013) Surgical Results of Synchronous Multiple Primary Lung Cancers: Similar to the Stage-Matched Soli-tary Primary Lung Cancers? The Annals of Thoracic Surgery, 96, 1966-1974.
https://doi.org/10.1016/j.athoracsur.2013.04.142
|
[4]
|
Chen, T.F., Xie, C.Y., Rao, B.Y., et al. (2019) Surgical Treatment to Multiple Primary Lung Cancer Patients: A Systematic Review and Meta-Analysis. BMC Surgery, 19, 185. https://doi.org/10.1186/s12893-019-0643-0
|
[5]
|
Shimada, Y., Saji, H., Otani, K., et al. (2015) Survival of a Surgi-cal Series of Lung Cancer Patients with Synchronous Multiple Ground-Glass Opacities, and the Management of Their Residual Lesions. Lung Cancer, 88, 174-180.
https://doi.org/10.1016/j.lungcan.2015.02.016
|
[6]
|
Li, R., Li, X., Xue, R., et al. (2018) Early Metastasis Detected in Patients with Multifocal Pulmonary Ground-Glass Opacities (GGOs). Thorax, 73, 290-292. https://doi.org/10.1136/thoraxjnl-2017-210169
|
[7]
|
Su, K., Gao, S., Ying, J., et al. (2018) Sequencing a Super Multiple Synchronous Lung Cancer Reveals a Novel Variant in Driver Gene ARID1B. The Journal of Thoracic and Cardiovascular Surgery, 155, e185-e191.
https://doi.org/10.1016/j.jtcvs.2018.01.010
|
[8]
|
Nikitas, J., DeWees, T., Rehman, S., et al. (2019) Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers. Clinical Lung Cancer, 20, 107-116. https://doi.org/10.1016/j.cllc.2018.10.010
|
[9]
|
Chang, Y.L., Wu, C.T. and Lee, Y.C. (2007) Surgical Treatment of Synchronous Multiple Primary Lung Cancers: Experience of 92 Patients. The Journal of Thoracic and Cardiovascular Surgery, 134, 630-637.
https://doi.org/10.1016/j.jtcvs.2007.06.001
|
[10]
|
Yang, H., Sun, Y., Yao, F., et al. (2016) Surgical Therapy for Bi-lateral Multiple Primary Lung Cancer. The Annals of Thoracic Surgery, 101, 1145-1152. https://doi.org/10.1016/j.athoracsur.2015.09.028
|
[11]
|
Zhao, L., Liu, C., Xie, G., Wu, F. and Hu, C. (2020) Multiple Primary Lung Cancers: A New Challenge in the Era of Precision Medicine. Cancer Management and Research, 12, 10361-10374. https://doi.org/10.2147/CMAR.S268081
|
[12]
|
Viale, G., Trapani, D. and Curigliano, G. (2017) Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy. BioMed Research International, 2017, Article ID: 4719194. https://doi.org/10.1155/2017/4719194
|
[13]
|
Mok, T.S.K., Wu, Y.L., Kudaba, I., et al. (2019) Pembrolizumab versus Chemotherapy for Previously Untreated, PD-L1-Expressing, Locally Advanced or Meta-static Non-Small-Cell Lung Cancer (KEYNOTE-042): A Randomised, Open-Label, Controlled, Phase 3 Trial. The Lan-cet, 393, 1819-1830. https://doi.org/10.1016/S0140-6736(18)32409-7
|
[14]
|
Singal, G., Miller, P.G., Agarwala, V., et al. (2019) Association of Patient Characteristics and Tumor Genomics with Clinical Outcomes among Patients with Non-Small Cell Lung Cancer Using a Clinicogenomic Database. JAMA, 321, 1391-1399. https://doi.org/10.1001/jama.2019.3241
|
[15]
|
Umansky, V., Blattner, C., Fleming, V., et al. (2017) Mye-loid-Derived Suppressor Cells and Tumor Escape from Immune Surveillance. Seminars in Immunopathology, 39, 295-305. https://doi.org/10.1007/s00281-016-0597-6
|
[16]
|
李瑛, 范忠义, 尤文叶, 杨俊兰, 焦顺昌. PD-1/PD-L1信号通路在肿瘤免疫逃逸中的作用及临床意义[J]. 解放军医学院学报, 2015, 36(7): 762-765.
|
[17]
|
Alsaab, H.O., Sau, S., Alzhrani, R., et al. (2017) PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome. Frontiers in Pharmacology, 8, 561.
https://doi.org/10.3389/fphar.2017.00561
|
[18]
|
Zak, K.M., Kitel, R., Przetocka, S., et al. (2015) Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1. Structure, 23, 2341-2348. https://doi.org/10.1016/j.str.2015.09.010
|
[19]
|
Provencio, M., Nadal, E., Insa, A., et al. (2019) Neoadjuvant Chemo-Immunotherapy for the Treatment of Stage IIIA Resectable Non-Small-Cell Lung Cancer (NSCLC): A Phase II Multicenter Exploratory Study—Final Data of Patients Who Underwent Surgical Assessment. Journal of Clinical On-cology, 37, 8509-8509.
https://doi.org/10.1200/JCO.2019.37.15_suppl.8509
|
[20]
|
Rusch, V., Chaft, J., Johnson, B., et al. (2018) Neoadju-vant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Initial Results from a Multicenter Study (LCMC3). Journal of Clinical Oncology, 36, 8541-8541.
https://doi.org/10.1200/JCO.2018.36.15_suppl.8541
|
[21]
|
Shihab, H.A., Rogers, M.F., Gough, J., et al. (2015) An Integrative Approach to Predicting the Functional Effects of Non-Coding and Coding Sequence Variation. Bioinformatics, 31, 1536-1543.
https://doi.org/10.1093/bioinformatics/btv009
|
[22]
|
Schwarz, J.M., Cooper, D.N., Schuelke, M., et al. (2014) Muta-tionTaster2: Mutation Prediction for the Deep-Sequencing Age. Nature Methods, 11, 361-362. https://doi.org/10.1038/nmeth.2890
|
[23]
|
Chen, H., Chong, W., Wu, Q., et al. (2019) Association of LRP1B Muta-tion with Tumor Mutation Burden and Outcomes in Melanoma and Non-Small Cell Lung Cancer Patients Treated with Immune Check-Point Blockades. Frontiers in Immunology, 10, 11-13. https://doi.org/10.3389/fimmu.2019.01523
|
[24]
|
Hsu, J., Hodgins, J.J., Marathe, M., et al. (2018) Contribution of NK Cells to Immunotherapy Mediated by PD-1/PD-L1 Blockade. Journal of Clinical Investigation, 128, 4654-4668. https://doi.org/10.1172/JCI99317
|
[25]
|
Daud, A.I., Loo, K., Pauli, M.L., et al. (2016) Tumor Immune Profiling Predicts Response to Anti-PD-1 Therapy in Human Melanoma. Journal of Clinical Investigation, 126, 3447-3452. https://doi.org/10.1172/JCI87324
|
[26]
|
Zhang, C., Zhang, J., Xu, F.P., et al. (2019) Genomic Landscape and Im-mune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma. Journal of Thoracic Oncol-ogy, 14, 1912-1923.
https://doi.org/10.1016/j.jtho.2019.07.031
|